179 related articles for article (PubMed ID: 12890213)
1. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
Mahé E; Descamps V; Grossin M; Fraitag S; Crickx B
Br J Dermatol; 2003 Jul; 149(1):170-3. PubMed ID: 12890213
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.
Di Lernia V; Ricci C
J Dermatolog Treat; 2011 Aug; 22(4):229-32. PubMed ID: 20666674
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
[TBL] [Abstract][Full Text] [Related]
4. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
[TBL] [Abstract][Full Text] [Related]
5. Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.
Pielop JA; Jones D; Duvic M
Int J Dermatol; 2001 Aug; 40(8):505-11. PubMed ID: 11703521
[TBL] [Abstract][Full Text] [Related]
6. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Laube S; Stephens M; Smith AG; Whittaker SJ; Tan BB
Br J Dermatol; 2005 Jun; 152(6):1346-8. PubMed ID: 15949007
[TBL] [Abstract][Full Text] [Related]
7. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
8. A case of mycosis fungoides with large cell transformation associated with infliximab treatment.
Suga H; Sugaya M; Toyama T; Sumida H; Fujita H; Kogure A; Igarashi A; Sato S
Acta Derm Venereol; 2014 Mar; 94(2):233-4. PubMed ID: 23975254
[No Abstract] [Full Text] [Related]
9. Efficacy of cyclosporine in the treatment of a case of infliximab-induced erythrodermic psoriasis.
Bruzzese V; Pepe J
Int J Immunopathol Pharmacol; 2009; 22(1):235-8. PubMed ID: 19309571
[TBL] [Abstract][Full Text] [Related]
10. A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: a case report and literature review.
Gattu S; Becker EM; Koo JY
J Drugs Dermatol; 2010 Oct; 9(10):1277-81. PubMed ID: 20941955
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
Lelièvre JD; Sacre K; Adle-Biassette H; Molinier-Frenkel V; Gaulard P; Papo T
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):24-7. PubMed ID: 15692507
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Aydin F; Canturk T; Senturk N; Turanli AY
Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
[TBL] [Abstract][Full Text] [Related]
13. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
[TBL] [Abstract][Full Text] [Related]
15. [Long term treatment of psoriasis with TNF-alpha antagonists. Occurrence of malignant melanoma].
Kowalzick L; Eickenscheidt L; Komar M; Schaarschmidt E
Hautarzt; 2009 Aug; 60(8):655-7. PubMed ID: 19280165
[TBL] [Abstract][Full Text] [Related]
16. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
17. Salt sensitivity of blood pressure in patients with psoriasis on ciclosporin therapy.
Magina S; Santos J; Coroas A; Oliveira JG; Serrão P; Soares-Da-Silva P; Resende C; Pestana M
Br J Dermatol; 2005 Apr; 152(4):773-6. PubMed ID: 15840112
[TBL] [Abstract][Full Text] [Related]
18. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
[TBL] [Abstract][Full Text] [Related]
19. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
20. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
